Perspective Therapeutics Inc (CATX)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Perspective Therapeutics Inc Stock (CATX) Company Profile

Perspective Therapeutics Inc

Healthcare (1115)

Medical Devices (143)

509-375-1202

350 Hills Street, Suite 106, Richland

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CATX's Discussions on Twitter

Compare CATX vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CATX Perspective Therapeutics Inc	4.16	436.37M	884.00K	-103.64M	-95.45M	-1.3944
ABT Abbott Laboratories	102.47	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	328.77	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.72	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.40	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	80.08	45.84B	6.07B	1.06B	1.34B	1.8063

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-19	Eingeleitet	Piper Sandler	Overweight
2025-11-24	Fortgesetzt	Truist	Buy
2025-10-10	Eingeleitet	BTIG Research	Buy
2025-03-13	Eingeleitet	H.C. Wainwright	Buy
2025-03-07	Eingeleitet	Scotiabank	Sector Outperform
2024-11-25	Herabstufung	BofA Securities	Buy → Neutral
2024-10-24	Eingeleitet	UBS	Buy
2024-10-01	Eingeleitet	Wedbush	Outperform
2024-09-25	Eingeleitet	Truist	Buy
2024-07-25	Eingeleitet	BofA Securities	Buy
2024-05-09	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten

Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Stock (CATX) Company Profile

Compare CATX vs ABT, SYK, MDT, BSX, EW

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten

Aug Analyst Calls: What is the next catalyst for Perspective Therapeutics IncGlobal Markets & Advanced Technical Analysis Signals - baoquankhu1.vn

Perspective Therapeutics Q1 EPS Raised by HC Wainwright - MarketBeat

CATX Technical Analysis | Trend, Signals & Chart Patterns | PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) - ChartMill

Investment Recap: What is the next catalyst for Perspective Therapeutics IncMarket Growth Report & Risk Controlled Daily Plans - baoquankhu1.vn

H.C. Wainwright raises Perspective Therapeutics price target to $13 By Investing.com - za.investing.com

CATX: HC Wainwright & Co. Raises Price Target to $13, Maintains Buy Rating | CATX Stock News - GuruFocus

H.C. Wainwright raises Perspective Therapeutics price target to $13 - Investing.com

Perspective Therapeutics (NYSEAMERICAN:CATX) Given New $13.00 Price Target at HC Wainwright - MarketBeat

PERSPECTIVE THERAPEUTICS INC (CATX) Fundamental Analysis & Valuation - ChartMill

Perspective Therapeutics, Inc.(NYSEAM:CATX) added to S&P Biotechnology Select Industry Index - marketscreener.com

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX) - The Globe and Mail

If You Invested $1,000 in Perspective Therapeutics Inc (CATX) - Stock Titan

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

CATX Should I Buy - Intellectia AI

Perspective Therapeutics Q1 EPS Boosted by Brookline Cap M - MarketBeat

Jones Trading reiterates Perspective Therapeutics stock Buy rating By Investing.com - Investing.com Australia

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX) - The Globe and Mail

Jones Trading reiterates Perspective Therapeutics stock Buy rating - Investing.com

Perspective Therapeutics (CATX) Receives Analyst Rating Boost | CATX Stock News - GuruFocus

B. Riley Financial Issues Positive Forecast for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price - MarketBeat

Perspective Therapeutics (CATX) Receives Analyst Rating Boost | - GuruFocus

Perspective Therapeutics (CATX) Receives Boost from UBS with Rai - GuruFocus

Perspective Therapeutics price target raised to $13 from $11 at B. Riley - TipRanks

UBS Adjusts Price Target on Perspective Therapeutics to $8 From $7, Maintains Buy Rating - marketscreener.com

UBS Group Forecasts Strong Price Appreciation for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock - MarketBeat

Perspective Therapeutics (CATX) Rating Reiterated by Wedbush | C - GuruFocus

Perspective Therapeutics (NYSEAMERICAN:CATX) Receives Outperform Rating from Wedbush - MarketBeat

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and IDEAYA Biosciences (IDYA) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT) - The Globe and Mail

B. Riley Raises Price Target on Perspective Therapeutics to $13 From $11, Keeps Buy Rating - marketscreener.com

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 - The Manila Times

Perspective Therapeutics (CATX) to Release Earnings on Wednesday - MarketBeat

RBC cuts Perspective Therapeutics stock price target on model updates By Investing.com - Investing.com Australia

Perspective Therapeutics Q4 2025 earnings preview - MSN

Truist reiterates Buy on Perspective Therapeutics stock By Investing.com - Investing.com Canada

BTIG Reiterates Buy Rating for CATX with $14 Price Target | CATX Stock News - GuruFocus

Royal Bank Of Canada Lowers Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target to $14.00 - MarketBeat

RBC Capital Lowers Price Target for CATX While Maintaining 'Outp - GuruFocus

Truist reiterates Buy on Perspective Therapeutics stock - Investing.com

RBC cuts Perspective Therapeutics stock price target on model updates - Investing.com

Perspective Therapeutics stock rating reiterated at Buy by BTIG - Investing.com South Africa

Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform By Investing.com - Investing.com South Africa

Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform - Investing.com

Perspective Therapeutics (NYSEAMERICAN:CATX) Receives "Buy" Rating from BTIG Research - MarketBeat

RBC Cuts Price Target on Perspective Therapeutics to $14 From $18, Keeps Outperform, Speculative Risk - marketscreener.com

Perspective Therapeutics, Inc. 2025 10-K Report: Advancing Targeted Alpha Therapy Radiopharmaceuticals for Cancer Treatment - minichart.com.sg

Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CATX